12 YEAR EXPERIENCE WITH THE MODIFIED BLALOCK-TAUSSIG SHUNT IN NEONATES

被引：55

作者：

FERMANIS, GG ^{[1
]}

EKANGAKI, AK ^{[1
]}

SALMON, AP ^{[1
]}

KEETON, BR ^{[1
]}

SHORE, DF ^{[1
]}

LAMB, RK ^{[1
]}

MONRO, JL ^{[1
]}

机构：

[1] SOUTHAMPTON GEN HOSP,WESSEX CARDIOTHORAC CTR,DEPT CARDIAC SURG,TREMONA RD,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND

来源：

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY | 1992年 / 6卷 / 11期

关键词：

NEONATE; SHUNT; SUDDEN DEATH;

D O I：

10.1016/1010-7940(92)90131-G

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Between 1978 and 1990, 53 consecutive modified Blalock-Taussig (MBT) shunts were performed on 51 neonates with cyanotic congenital heart disease using 3 mm-5 mm Gore-Tex grafts. Only 4 of these children had uncomplicated tetralogy of Fallot. The remainder had more complicated pathology requiring urgent intervention. Retrospective analysis of the acute and long term results was performed with 100% follow-up, ranging from 1 month to 12 years (mean 3 years). There were 3 (6%) early deaths (within 30 days of operation) and 17 (33%) late deaths. Of the late deaths, 2 died after further palliation, 2 died after total correction and 13 died suddenly at home. Post mortem examination of the 13 sudden deaths revealed blocked shunts in only 3. Actuarial survival at 2 years was 58%. Shunt patency at 12 months was 87% and at 2 years, 62%. No patient used their initial MBT shunt for more than 40 months. Although this shunt provides good initial palliation, there is a high incidence of late sudden death. We are also concerned about the limited life span of the shunt which partly (3/13) explains the sudden deaths. Therefore we have adopted an aggressive approach to re-study by angiography within 3 months of surgery.

引用

页码：586 / 589

页数：4

共 12 条

[1]

Bove E.L., Sondheimer H.M., Kavey R.-E.W., Bryum C.J., Blackman M.S., Parker F.B., Subclavian-pulmonary artery shunts with polytetrafluoroetyhlene interposition grafts, Ann Thorac Surg, 37, pp. 88-91, (1984)

[2]

de Levai M.R., McKay R., Jones M., Stark J., McArtney F.J., Modified Blalock-Taussig shunt. Use of subclavian artery orifice as a flow regulator in prosthetic systemic pulmonary artery shunts, J Thorac Cardiovasc Surg, 81, pp. 112-119, (1981)

[3]

Di Benedetto G., Tiraboschi R., Vanini V., Annechino P., Aizza L., Caprioli C., Parenzan L., Systemic-pulmonary artery shunt using PTFE prosthesis (Gore-Tex). Early results and long-term follow-up in 105 consecutive cases, Thorac Cardiovasc Surg, 29, pp. 143-147, (1981)

[4]

Donahoo J.S., Gardner T.J., Zahka K., Langford-Kidd B.S., Systemic-pulmonary shunts in neonates and infants using microporous expanded polytetrafluoroethylene: Immediate and late results, Ann Thorac Surg, 30, pp. 146-150, (1980)

[5]

Edmunds H., Stephenson L.W., Gadzik J.P., The Blalock-Taussig anastomosis in infants younger than one week of age, Circulation, 62, pp. 597-603, (1980)

[6]

Elliot L.P., Adams P., Edwards J.E., Pulmonary atresia with intact ventricular septum, Br Heart J, 25, pp. 489-501, (1963)

[7]

Gazzaniga A.B., Lamberti J.J., Siewers R.D., Sperling D.R., Di-etrick W.R., Arcilla R.A., Replogle R.L., Arterial prosthesis of microporous expanded polytetrafluoroethylene for construction of aorto-pulmonary shunts, J Thorac Cardiovasc Surg, 72, pp. 357-363, (1976)

[8]

Ilbawi M.N., Grieco J., DeLeon S.Y., Idriss F.S., Muster A.J., Berry T.E., Klich J., Modified Blalock-Taussig shunt in newborn infants, J Thorac Cardiovasc Surg, 88, pp. 770-775, (1984)

[9]

Kay P.H., Capuani A., Franks R., Lincoln C., Experience with the modified Blalock-Taussig operation using polytetrafluoroethylene (Impra) grafts, Br Heart J, 49, pp. 359-363, (1983)

[10]

Klinner W., Pasini M., Schaudig A., Anastomose zwischen System und Lungenarterie mit Hilfe von Kunststoffprothesen bei cyanotischen Herzvitien, Thoraxchir Vask Chir, 10, pp. 68-75, (1962)

← 1 2 →